What is wrong in Denmark?

This paper addresses Public Private Partnerships (PPP) and Pharmaceutical Public Private Partnerships (PPPP) in Denmark or the lack of PPP(P)’s in Denmark. It would seem, that the market for PPP(P)’s in Denmark is either very small, non-existing or it might be disturbed by several factors: legal and political, business and structural. Besides pointing out some relevant key factors preventing PPP’s, the paper presents some new information: It is not only in the infrastructure industry that the lack of PPP is significant. The idea of establishing PPPP’s between the private pharmaceutical industry and the university sector is also problematic. This paper identifies that the creation of a common PPP business case is difficult in Denmark in both the infrastructure and the pharmaceutical industry